Urban, A.; Majeranowski, A.; Stasiłojć, G.; Koszałka, P.; Felberg, A.; Taszner, M.; Zaucha, J.M.; Okrój, M.
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies. Cancers 2022, 14, 1270.
https://doi.org/10.3390/cancers14051270
AMA Style
Urban A, Majeranowski A, Stasiłojć G, Koszałka P, Felberg A, Taszner M, Zaucha JM, Okrój M.
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies. Cancers. 2022; 14(5):1270.
https://doi.org/10.3390/cancers14051270
Chicago/Turabian Style
Urban, Aleksandra, Alan Majeranowski, Grzegorz Stasiłojć, Patrycja Koszałka, Anna Felberg, Michał Taszner, Jan M. Zaucha, and Marcin Okrój.
2022. "In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies" Cancers 14, no. 5: 1270.
https://doi.org/10.3390/cancers14051270
APA Style
Urban, A., Majeranowski, A., Stasiłojć, G., Koszałka, P., Felberg, A., Taszner, M., Zaucha, J. M., & Okrój, M.
(2022). In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies. Cancers, 14(5), 1270.
https://doi.org/10.3390/cancers14051270